Accreditation

0.75 AMA PRA Category 1 Credit(s)™.
Read the full Accreditation Statement

Target Audience

Cardiologists, Cardiac Surgeons, and other interested healthcare professionals.

Description

Emerging Therapies in Heart Disease offers presentations and discussions of patient history and new surgical advancements coupled with a live interactive discussion with program faculty.

Objectives

At the conclusion of this activity, the participant will be able to:

1. Explain the pathophysiology of mitral regurgitation and its effects on left ventricular dynamics, left atrial pressure, heart rhythm, and clinical outcomes.
2. List the mechanisms and etiologies of mitral regurgitation, and the key echocardiographic features of each type.
3. Characterize the impact of echo-derived mechanism of mitral regurgitation on the outcome of surgical repair in comparison to mitral valve replacement. 
4. Recognize the technique employed for mitral valve repair.
5. Discuss the long-term durability of mitral valve repair.

Activity Directors

A. Marc Gillinov, MD
Series Co-Director
Surgical Director
Center for Atrial Fibrillation
Thoracic and Cardiovascular Surgery
Cleveland Clinic Heart & Vascular Institute

William J. Stewart, MD FACC, FASE
Series Co-Director
Cardiovascular Medicine
Section of Cardiovascular Imaging
Cleveland Clinic Heart and Vascular Institute
Associate Professor of Medicine
Cleveland Clinic Lerner College
of Medicine of Case Western Reserve University

Author / Faculty

A. Marc Gillinov, MD; William J. Stewart, MD FACC, FASE

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Marc Gillinov, MD — Consultant: AtriCure, Inc. & Edwards Lifesciences
                           — Shareholder: Viacor

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

William J. Stewart, MD